William Lis's most recent trade in Zai Lab Limited - ADR was a trade of 13,814 American Depositary Shares done at an average price of $35.7 . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zai Lab ADR | William David Lis | Director | Sale of securities on an exchange or to another person at price $ 35.67 per share. | 18 Jun 2025 | 13,814 | 35,106 (0%) | 0% | 35.7 | 492,745 | American Depositary Shares |
| Zai Lab ADR | William David Lis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 10,831 | 48,920 (0%) | 0% | 0 | American Depositary Shares | |
| Zai Lab ADR | William Lis David | Director | Sale of securities on an exchange or to another person at price $ 32.98 per share. | 28 Feb 2025 | 15,000 | 38,089 (0%) | 0% | 33.0 | 494,700 | American Depositary Shares |
| Zai Lab ADR | William Lis | Director | Sale of securities on an exchange or to another person at price $ 17.31 per share. | 01 Jul 2024 | 10,297 | 53,189 (0%) | 0% | 17.3 | 178,281 | American Depositary Shares |
| Zai Lab ADR | William Lis | Director | Sale of securities on an exchange or to another person at price $ 18.04 per share. | 01 Jul 2024 | 100 | 53,089 (0%) | 0% | 18.0 | 1,804 | American Depositary Shares |
| Zai Lab ADR | William Lis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 21,253 | 63,486 (0%) | 0% | 0 | American Depositary Shares | |
| Jasper Therapeutics Inc | William Lis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 47,000 | 47,000 | - | - | Stock Option (right to buy) | |
| Jasper Therapeutics Inc | William Lis | Director | Sale of securities on an exchange or to another person at price $ 1.44 per share. | 13 Apr 2023 | 8,500 | 61,486 | - | 1.4 | 12,240 | Voting Common Stock |
| Jasper Therapeutics Inc | William Lis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2022 | 29,500 | 69,986 | - | 0 | Voting Common Stock | |
| Jasper Therapeutics Inc | William Lis | Director | Sale of securities on an exchange or to another person at price $ 2.02 per share. | 24 Jun 2022 | 24,743 | 65,229 | - | 2.0 | 50,030 | Voting Common Stock |
| Jasper Therapeutics Inc | William Lis | Director | Sale of securities on an exchange or to another person at price $ 2.08 per share. | 24 Jun 2022 | 24,743 | 40,486 | - | 2.1 | 51,404 | Voting Common Stock |
| Jasper Therapeutics Inc | William Lis | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Jasper Therapeutics Inc | William Lis | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 89,972 | 89,972 | - | - | Stock Option (right to buy) | |
| Jasper Therapeutics Inc | William Lis | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 89,972 | 89,972 | - | 0 | Voting Common Stock | |
| Jasper Therapeutics Inc | William Lis | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 7,500 | 7,500 | - | - | Stock Option (right to buy) |